POY_1170x120_8-12-19

policy to improve access and foster price competition for drugs that face inadequate generic competition

FDA issues statement on new policy for pricing of generic drugs

FDA issues statement on new policy for pricing of generic drugs

SILVER SPRING, Md. — FDA Commissioner Dr. Scott Gottlieb issued the following statement Friday on a new policy to improve access and foster price competition for drugs that face inadequate generic competition: “In too many cases, branded drugs that are no longer protected by patents or other exclusivities do not face expected competition. In fact,